About
Longhorn Life Sciences Inc. (LLS) is a MedTech venture led by a strong and diverse team of scientists, clinicians, and entrepreneurs at UT Austin and MD Anderson. Our mission is to develop needs-driven medical technology to improve patient outcomes and experiences.Here's our story so far...
-
Spring 2021
Our Humble Beginnings
Our team came together as part of the inagural Texas Biodesign program. The program was geared at teaching a Needs-Based approach to innovation in the medical sector. Our team identified several quality needs, eventually leading to the idea-inception of the Infection Detective.
-
July 2021
Longhorn Life Sciences is Founded
After completing the Texas Biodesign program our team began pursuing development of the Infection Detective. By the summer of 2021 we had taken an important step in bringing our technolgy forward, incorporating as a Delaware C Corp.
-
2021-Present
Engaging Strategic Partners
During our tenure as a company we’ve sought out strategic parnterships, including NASAs Office of Technology Transfer.
-
Spring 2021 - Fall 2021
Venturewell E-Team
We were selected as an E-team in the prestiguous Venturewell E-team program at the Pioneer, and Propel levels. We participated in their workshops where we received coaching, mentorship, and conducted a series of customer discovery interviews that helped us adapt and improve on our value propositions, and our market strategies.
-
Fall 2021 - Present
Pitch Competitions
Over the past year we’ve competed in several pitch competitions. We’ve participated twice in the prestigous Texas Venture Labs Investment Competition where we won 5 awards incuding the award for the top health innovation. We were an alternate for the Texas A&M New Ventures Competition where we won the elevator pitch and 2 other awards.
-
Spring 2022 - Present
Customer Discovery Interviews
The team, led by Miles Massidda and Dr. Cristina Checka, have completed 75 customer discovery interviews to date through business mentorship programs (VentureWell and Washington University’s Equalize). The interviews have targeted doctors, nurses, patients, and clinical purchasing teams to validate the clinical need for the device, mitigate regulatory hurdles, and identify viable sales channels.
-
Be Part
of Our
Story!
